drugset / Trial / NCT04854993

Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy

NCT04854993

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this prospecive randomized study is to evaluate the effects of a dose of sugammadex increased by 50% compared to a standard dose on recovery time from deep neuromuscular block in elderly patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Secondary objectives are to evaluate the different extubation time, time to exit from the operating room (OR), lenght of stay in post-anaesthesia care unit (PACU) and safety (hemodynamic parameters and respiratory function).

Timeline

Start
2021-07-13
Primary completion
2022-09-20
Completion
2022-09-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 4 mg/kg Intravenous
Subject Sugammadex Other / unclassified 6 mg/kg Intravenous

Indications